the development of large language models (LLMs) is a recent success in the field of generative artificial intelligence (AI). they are computer models able to perform a wide range of natural language processing tasks, including content generation, question answering, or language translation. In recent months, a growing number of studies aimed to assess their potential applications in the field of medicine, including cancer care. In this mini review, we described the present published evidence for using LLMs in oncology. all the available studies assessed ChatGPT, an advanced language model developed by openAI, alone or compared to other LLMs, such as google bard, chatsonic, and perplexity. although ChatGPT could provide adequate information on the screening or the management of specific solid tumors, it also demonstrated a significant error rate and a tendency toward providing obsolete data. therefore, an accurate, expert-driven verification process remains mandatory to avoid the potential for misinformation and incorrect evidence. overall, although this new generative AI-based technology has the potential to revolutionize the field of medicine, including that of cancer care, it will be necessary to develop rules to guide the application of these tools to maximize benefits and minimize risks.
Iannantuono, G.m., Bracken-Clarke, D., Floudas, C.s., Roselli, M., Gulley, J.l., Karzai, F. (2023). Applications of large language models in cancer care: current evidence and future perspectives. FRONTIERS IN ONCOLOGY, 13 [10.3389/fonc.2023.1268915].
Applications of large language models in cancer care: current evidence and future perspectives
Iannantuono, Giovanni Maria
;Roselli, Mario;
2023-01-01
Abstract
the development of large language models (LLMs) is a recent success in the field of generative artificial intelligence (AI). they are computer models able to perform a wide range of natural language processing tasks, including content generation, question answering, or language translation. In recent months, a growing number of studies aimed to assess their potential applications in the field of medicine, including cancer care. In this mini review, we described the present published evidence for using LLMs in oncology. all the available studies assessed ChatGPT, an advanced language model developed by openAI, alone or compared to other LLMs, such as google bard, chatsonic, and perplexity. although ChatGPT could provide adequate information on the screening or the management of specific solid tumors, it also demonstrated a significant error rate and a tendency toward providing obsolete data. therefore, an accurate, expert-driven verification process remains mandatory to avoid the potential for misinformation and incorrect evidence. overall, although this new generative AI-based technology has the potential to revolutionize the field of medicine, including that of cancer care, it will be necessary to develop rules to guide the application of these tools to maximize benefits and minimize risks.File | Dimensione | Formato | |
---|---|---|---|
Iannantuono Frontiers 2023.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
567.29 kB
Formato
Adobe PDF
|
567.29 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.